A phase 3 trial analysis confirms the efficacy and safety of perfluorohexyloctane for dry eye disease across a range of baseline severities.
More than 3.1 million bottles of over-the-counter eye drops are being recalled due to concerns about sterility. While no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results